id: NEW:alcohol_related_liver_disease_prevalence_to_liver_disease_mortality
name: Alcohol Related Liver Disease Prevalence â†’ Liver Disease Mortality
from_node:
  node_id: NEW:alcohol_related_liver_disease_prevalence
  node_name: Alcohol Related Liver Disease Prevalence
to_node:
  node_id: liver_disease_mortality
  node_name: Liver Disease Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic alcohol consumption causes direct hepatotoxic injury to liver cells,
  leading to a spectrum of alcohol-related liver diseases (ARLD) including fatty liver,
  alcoholic hepatitis, and cirrhosis'
- 'Step 2: Progressive liver damage leads to fibrosis and cirrhosis (comprising 32.9%
  of ARLD spectrum), with associated complications including ascites (25.1% prevalence
  in ARLD population)'
- 'Step 3: Advanced liver disease results in liver failure, portal hypertension, and
  hepatocellular carcinoma, leading to liver-related mortality (21.6% liver-specific
  mortality rate among ARLD patients)'
- 'Step 4: Overall mortality among ARLD patients reaches 23.9%, reflecting both direct
  liver-related deaths and systemic complications of chronic liver disease'
evidence:
  quality_rating: A
  n_studies: 372
  primary_citation: 'Xuanxuan Niu et al. 2023. Global prevalence, incidence, and outcomes
    of alcohol related liver diseases: a systematic review and meta-analysis. BMC
    Public Health.'
  supporting_citations: []
description: 'Alcohol-related liver disease (ARLD) directly leads to liver disease
  mortality through progressive hepatic injury. This systematic review of 372 studies
  found that ARLD has a global prevalence of 4.8%, with alcoholic liver cirrhosis
  comprising the highest proportion (32.9%) of the disease spectrum. The mortality
  burden is substantial: overall mortality among ARLD patients is 23.9%, with liver-specific
  mortality at 21.6%. Disease progression is driven by chronic alcohol exposure, with
  patients typically having >20 years of heavy drinking (average 146.6 g/day). Complications
  such as ascites affect 25.1% of patients, reflecting advanced liver decompensation.'
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 21.6
    type: mortality_rate_percent
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: null
moderators:
- name: sex
  direction: strengthens
  strength: strong
  description: Male prevalence (2.9%) significantly higher than female (0.5%), indicating
    higher risk in males
- name: drinking_duration
  direction: strengthens
  strength: strong
  description: 54.8% of ARLD patients had drinking history >20 years, with average
    daily intake of 146.6 g/d
- name: smoking_status
  direction: strengthens
  strength: moderate
  description: 59.5% of ARLD patients were current or former smokers, potentially
    accelerating liver damage
- name: hepatitis_coinfection
  direction: strengthens
  strength: moderate
  description: 18.7% of ARLD patients had hepatitis virus coinfection, compounding
    liver injury
